Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded active-controlled comparative clinical study over 52 weeks. - Blauvelt, Andrew; Papp, Kim; Trivedi, Mona; Barragan, Carolina; Chow, Vincent; Mytych, Daniel T; Yamauchi, Paul; Crowley, Jeff; Franklin, Janet (British Journal of Dermatology, 2025)